Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 6,289 | 6,633 | 4,693 | 3,859 | 4,471 |
| Operating Income | -6,289 | -6,633 | -4,693 | -3,859 | -4,471 |
| Interest Expense | 706 | 1,001 | 95 | 1 | 0 |
| Other Income | 436 | 8,687 | -14,405 | 767 | 1,294 |
| Pre-tax Income | -6,559 | 1,053 | -19,193 | -3,093 | -3,177 |
| Income Tax | 2 | 2 | 2 | 2 | 2 |
| Net Income Continuous | -6,561 | 1,052 | -19,194 | -3,094 | -3,178 |
| Net Income | $-6,561 | $1,052 | $-19,194 | $-3,094 | $-3,178 |
| EPS Basic Total Ops | -7.50 | 2.50 | -40.00 | -27.50 | -42.50 |
| EPS Basic Continuous Ops | -7.11 | 1.95 | -39.61 | -27.72 | -41.93 |
| EPS Diluted Total Ops | -7.50 | -12.50 | -40.00 | -27.50 | -42.50 |
| EPS Diluted Continuous Ops | -7.09 | 1.55 | -39.61 | -27.72 | -41.93 |
| EPS Diluted Before Non-Recurring Items | -7.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,743 | $-6,002 | $-4,632 | $-3,821 | $-4,404 |